510(k) Report

FDA product code · Orthopedic

Prosthesis, Hip, Semi-Constrained, Ceramic-On-Metal Articulation

OVOClass IIIPMA required1 decision since 20110 recalls

1 FDA decision since 2011. No recall names this code.

Intended as a primary joint replacement prosthesis in total hip arthroplasty.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, orthopedic panel

Twenty years of OVO at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · OVO

1in 2013

2011: 22012: 62013: 1
2007high 6 (2012) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OVO

Too few OVO 510(k)s in any year since 2007 to give a median.

Recalls per year · OVO

No recall names OVO since 2007.

Adverse event reports per year · OVO

3in 2020

2008: 12012: 12016: 12017: 62018: 82019: 22020: 3
2007high 8 (2018) · low 0 (2007)2025

MAUDE reports naming product code OVO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—01
20090—00
20100—00
20112—00
20126—01
20131—00
20140—00
20150—00
20160—01
20170—06
20180—08
20190—02
20200—03
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
FIG. 1 — OVO by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in OVO? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report